Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Trial of HSG4112 in Overweight and Obese Patients
KCT0007001Phase 2Completed
- Sponsor
- Glaceum
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity and Overweight comparing HSG4112 with Placebo (2 arms). Started Mar 2022; status: completed.
02
Drugs
vutiglabridin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on KCT0007001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007001.